Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arsene Musana Habimana has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence, Antimicrobial Resistance, and Virulence Profiles of Thermophilic Campylobacter Isolated From Meat in Selected Regions of Rwanda

    by Arsene Musana Habimana, Salomon Ntwali, Jean Bosco Shimirwa, Josee Izaturinde, Grace Uwineza, Anathalie Umuhoza, Benon Turatsinze, Emmanuel Erick V. G. Komba, Raghavendra G. Amachawadi, Claude M. Muvunyi, et al.

    Campylobacter species are among the leading causes of human gastroenteritis, with improperly prepared meat identified as a major transmission source. In Rwanda, data on the epidemiology of Campylobacter are scarce. This study aimed at assessing the prevalence, antimicrobial resistance, and virulence gene profiles of thermophilic Campylobacter species isolated from meat in selected regions of Rwanda. A total of 304 meat samples were collected from slaughterhouses and markets across Kigali, Huye, and Gisagara Districts. The samples included meat from chicken ( n = 50), goat ( n = 45), pig ( n = 43), sheep ( n = 41), and cow ( n = 125). Campylobacter spp. were isolated using enrichment and subsequent selective media. Antimicrobial susceptibility testing against six antimicrobials (ciprofloxacin [CIP], erythromycin [ERY], streptomycin [STR], tetracycline [TET], gentamicin [GEN], and chloramphenicol [CHL]) was performed using the disc diffusion method. The polymerase chain reaction (PCR) was used to identify genus and species, as well as the detection of selected resistance ( tet O, cme B, and cjgyr A) and virulence ( cad F, cia B, and cdt B) genes. The prevalence of Campylobacter spp. was 25% (76/304), with C. jejuni and C. coli accounting for 89.47% (68/76) and 10.53% (8/76), respectively. Campylobacter was detected in 56% (28/50). The highest resistance was recorded against ERY (94.7%), followed by STR (84.2%) and TET (81.6%), while isolates were sensitive to GEN (98.7%). Multidrug resistance (MDR) was observed in 84.2% of isolates. The frequencies of resistance genes were 89.5% and 59.2% for tetO and cme B, respectively. Additionally, cia B, cad F, and cdt B were detected in 89.5%, 78.9%, and 55.3% of the samples, respectively. The presence of virulent and multidrug‐resistant Campylobacter in meat underscores the urgent need for enhanced food hygiene practices, regulated antibiotic use in livestock, and coordinated One Health surveillance strategies to mitigate public health risks. These findings indicate substantial food safety risks associated with retail meat in Rwanda and highlight critical gaps in hygiene practices and antimicrobial stewardship along the meat value chain.

  • Open Access

    Leveraging the Polymorphism of the Merozoite Surface Protein 2 (MSP2) to Engineer Molecular Tools for Predicting Malaria Episodes in a Community

    by Edgar Mutebwa Kalimba, Sandra Fankem Noukimi, Jean-Bosco Mbonimpa, Cabirou Mounchili Shintouo, Radouane Ouali, Mariama Telly Diallo, Antoine Vicario, Samuel Vandecasteele, Abenwie Suh Nchang, Lahngong Methodius Shinyuy, et al.

    Malaria remains a significant public health challenge, particularly in endemic regions. The extensive genetic diversity of Plasmodium falciparum (Pf) complicates outbreak prediction and transmission control. One of its most polymorphic markers, merozoite surface protein 2 (MSP2), presents a potential target for molecular surveillance. This cross-sectional study, conducted at King Faisal Hospital Rwanda (KFHR) from October 2021 to June 2023, assessed MSP2’s utility in malaria prediction. PfMSP2 was sequenced, and selected amplicons were cloned, expressed in bacteria, and purified. These antigens were tested against sera from malaria patients and geographically diverse healthy individuals, with complementary surveys contextualizing serological findings. Of the 75 processed monoallelic clinical isolates, 3D7 strains predominated over FC27. Three MSP2-derived biomarkers were produced, eliciting significantly low IgG responses in malaria patients and Belgian controls, but a complex pattern emerged in healthy individuals, with significant differences between Rwandan and Cameroonian samples. IgG3 was the predominant subclass in individuals with high IgG responses. Notably, Rwandan individuals with weak humoral responses to the tested antigens but also other with high responses experienced malaria episodes in the subsequent year. These findings highlight MSP2 polymorphism as a valuable tool for malaria surveillance and outbreak prediction. Integrating genotyping and serology could enable precise, community-specific malaria risk assessments, strengthening control strategies.